Oregon Cancer

News and information for cancer services throughout Oregon.

  • Honoring our physicians on Doctors’ Day

    Honoring our physicians on Doctors’ Day

    In honor of Doctors' Day on March 30, we recognize the significant contributions of physicians and their commitment to providing the most advanced, highest quality care for our cancer patients.

    Read Article
  • Targeted therapies are the focus of new studies for colorectal and bile duct cancers

    Targeted therapies are the focus of new studies for colorectal and bile duct cancers

    New trials available at Earle A. Chiles Research Institute for patients with human epidermal growth factor receptor 2 positive (HER2+) colorectal cancer and patients with cholangiocarcinoma.

    Read Article
  • Celebrating our oncology social workers

    Celebrating our oncology social workers

    In honor of Social Work Month we recognize the incredible contributions of oncology social workers.

    Read Article
  • Cancer vaccine is focus of breast cancer study at Providence

    Cancer vaccine is focus of breast cancer study at Providence

    A new trial offered at Providence Cancer Institute is enrolling patients with early-stage HR-positive and HER2-negative breast cancer.

    Read Article
  • AACR Project GENIE: Making an impact worldwide in cancer research and precision medicine

    AACR Project GENIE: Making an impact worldwide in cancer research and precision medicine

    As part of an international data-sharing consortium of leading cancer centers, Providence Cancer Institute and Swedish Cancer Institute work together to provide genomic data to Project GENIE.

    Read Article
  • MRI-guided radiotherapy is a gamechanger in treating prostate cancer

    MRI-guided radiotherapy is a gamechanger in treating prostate cancer

    Using MRI-guided radiation, Providence radiation oncologists can precisely target tumors for destruction while minimizing damage to surrounding normal tissue.

    Read Article
  • New study opens for non-GCB DLBCL patients under age 70

    New study opens for non-GCB DLBCL patients under age 70

    A new clinical trial offered at Providence Cancer Institute to study the safety and effectiveness of two different treatments for people under age 70 with previously untreated non-GCB DLBCL.

    Read Article
  • Celebrating a year of community engagement

    Celebrating a year of community engagement

    Providence Cancer Institute highlights a year of engaging with and supporting our patients, partner organizations and community.

    Read Article
  • Three phases of clinical trials round out a year of research advancements

    Three phases of clinical trials round out a year of research advancements

    Providence Cancer Institute is offering a phase III trial for patients with gynecologic cancers and two early phase trials that will study new medications in treating solid tumors.

    Read Article
  • Fellowship trains next generation of immuno-oncology experts

    Fellowship trains next generation of immuno-oncology experts

    Providence currently accepting applications for an Immuno-Oncology Research Fellowship being offered through Earle A. Chiles Research Institute.

    Read Article
  • Providence immunologist honored at leading cancer conference

    Providence immunologist honored at leading cancer conference

    Bernard A. Fox, Ph.D., leader of the Laboratory of Molecular and Tumor Immunology honored by the Society for Immunotherapy of Cancer for legacy of public service.

    Read Article
  • Learn how integrative medicine can improve quality of life for cancer patients

    Learn how integrative medicine can improve quality of life for cancer patients

    Providence Cancer Institute to hold two virtual events on the benefits of integrative medicine for patients.

    Read Article
  • Providence among few sites worldwide offering new trials for solid tumors and lung cancer

    Providence among few sites worldwide offering new trials for solid tumors and lung cancer

    Providence Cancer Institute one of only a few sites worldwide offering two new clinical trials for solid tumors and lung cancer.

    Read Article
  •  Three new studies are focus of Breast Cancer Awareness Month

    Three new studies are focus of Breast Cancer Awareness Month

    Providence Cancer Institute is currently recruiting participants for three new clinical studies offered for people with HER2-neu negative breast cancer.

    Read Article
  • Providence lung cancer experts to present at oncology summit

    Providence lung cancer experts to present at oncology summit

    Leading lung cancer professionals to gather in November for premier oncology summit.

    Read Article
  • Medical expert shares promising treatments and latest research for gynecologic cancers

    Medical expert shares promising treatments and latest research for gynecologic cancers

    Providence gynecologic oncologist Christopher Darus, M.D. shares the latest research and promising treatments for gynecologic cancers.

    Read Article
  • Understanding lymphoma: The Basics and Beyond with Dr. Natasha Edwin

    Understanding lymphoma: The Basics and Beyond with Dr. Natasha Edwin

    Providence hematology expert offers the most updated information about lymphoma, treatment options and helpful community resources.

    Read Article
  • New trial is first to study targeted therapy combination for treating thyroid cancer

    New trial is first to study targeted therapy combination for treating thyroid cancer

    New investigator-initiated clinical trial available only at Providence Cancer Institute will evaluate the safety and efficacy of targeted therapy combination for treating thyroid cancer.

    Read Article
  • Providence Cancer Institute shares updates on advances in care for melanoma patients

    Providence Cancer Institute shares updates on advances in care for melanoma patients

    Providence Cancer Institute experts share their insights on recent advances in melanoma research and care, and tips on communicating with loved ones in a virtual symposium.

    Read Article
  • Shorter treatment duration with new therapy is focus of rectal cancer trial

    Shorter treatment duration with new therapy is focus of rectal cancer trial

    New Providence-sponsored study may provide new insights into the efficacy of shorter duration radiation and chemotherapy treatment before surgery for people with stage II/III rectal cancer

    Read Article
  • loading
    Loading More...